NR1H3 and breast cancer: We previously demonstrated that ER-negative breast cancer was highly responsive to LXRα signaling compared to other breast cancer types [24] suggesting retention of the scOHC:LXR axis provided a survival advantage to TNBC tumors that persisted despite the anti-proliferative actions LXR confers.